Bruxism and oral parafunctional hyperactivity in social phobia outpatients

Summary Anxiety and selective serotonin reuptake inhibitors (SSRIs) are considered aggravating factors for bruxism. We examined the influence of anxiety, depression and SSRI on bruxism in social phobia (SP). Twenty‐three drug naïve, 17 SSRI‐treated SP patients and 33 healthy controls underwent a psy...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of oral rehabilitation Vol. 42; no. 2; pp. 90 - 97
Main Authors:	Hermesh, H., Schapir, L., Marom, S., Skopski, R., Barnea, E., Weizman, A., Winocur, E.
Format:	Journal Article
Language:	English
Published:	England Blackwell Publishing Ltd 01-02-2015
Subjects:	Adult Anti-Anxiety Agents - administration & dosage Anti-Anxiety Agents - adverse effects Anxiety - complications Anxiety - therapy bruxism Bruxism - etiology Bruxism - psychology Bruxism - therapy clenching Dentistry depression Depression - complications Depression - therapy Female Humans Male Middle Aged Outpatients Phobic Disorders - complications Phobic Disorders - psychology Phobic Disorders - therapy Psychiatric Status Rating Scales selective serotonin reuptake inhibitors Serotonin Uptake Inhibitors - administration & dosage Serotonin Uptake Inhibitors - adverse effects social phobia depression bruxism social phobia selective serotonin reuptake inhibitors clenching
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Summary Anxiety and selective serotonin reuptake inhibitors (SSRIs) are considered aggravating factors for bruxism. We examined the influence of anxiety, depression and SSRI on bruxism in social phobia (SP). Twenty‐three drug naïve, 17 SSRI‐treated SP patients and 33 healthy controls underwent a psychiatric assessment and completed Leibowitz Social Anxiety Scale and Beck Depression Inventory. Oral parafunctional activity (PF) was evaluated by TM‐dental examination and by a questionnaire. Drug‐ naïve and SSRI‐treated SP patients did not differ on demographic and clinical measures. Awake bruxism, ‘JAW PLAY’ and at least one PF were more prevalent in SP than in controls. Severity of SP predicted the presence of PF. SP, but not depression, was associated with higher risk of oral PF and awake bruxism. Chronic SSRI treatment of SP did not affect sleep and awake bruxism. Dental and anxiety screening may improve the prognosis psychiatric and dental patients. Effective treatment of SP may mitigate bruxism.
Bibliography:	ark:/67375/WNG-ZND4N8X4-F istex:C3F2751170965BCCCBE3A16DBB809F9FB8AA53C0 Ethics Committee of Tel Aviv University ArticleID:JOOR12235 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0305-182X 1365-2842
DOI:	10.1111/joor.12235